Aspiriant LLC’s Vanguard Extended Market ETF VXF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$757K Hold
3,680
0.02% 179
2025
Q4
$770K Sell
3,680
-2,113
-36% -$444K 0.02% 175
2025
Q3
$1.21M Hold
5,793
0.04% 134
2025
Q2
$1.12M Buy
5,793
+2,113
+57% +$375K 0.04% 142
2025
Q1
$634K Hold
3,680
0.02% 169
2024
Q4
$699K Hold
3,680
0.03% 167
2024
Q3
$670K Sell
3,680
-10
-0.3% -$1.75K 0.03% 170
2024
Q2
$623K Hold
3,690
0.03% 174
2024
Q1
$647K Hold
3,690
0.03% 170
2023
Q4
$607K Hold
3,690
0.03% 176
2023
Q3
$529K Hold
3,690
0.03% 172
2023
Q2
$549K Buy
3,690
+10
+0.3% +$1.4K 0.03% 173
2023
Q1
$516K Hold
3,680
0.03% 172
2022
Q4
$489K Sell
3,680
-11
-0.3% -$1.49K 0.02% 181
2022
Q3
$469K Buy
3,691
+11
+0.3% +$1.55K 0.02% 173
2022
Q2
$482K Hold
3,680
0.02% 168
2022
Q1
$610K Sell
3,680
-1,203
-25% -$198K 0.03% 162
2021
Q4
$893K Buy
+4,883
New +$918K 0.05% 145

Other funds holding VXF

Aspiriant LLC's VXF Position: Q1 2026 in Review

Aspiriant LLC held its Vanguard Extended Market ETF (VXF) position steady in Q1 2026 at 3,680 shares worth $757K. The position accounts for 0.02% of the portfolio, ranked #179.

Aspiriant LLC first reported a position in VXF in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.21M in Q3 2025. 1,002 funds tracked by Wall St. Rank hold VXF as of Q1 2026.

  • Aspiriant LLC held 3,680 shares of Vanguard Extended Market ETF worth $757K as of Q1 2026.
  • Aspiriant LLC left its Vanguard Extended Market ETF share count unchanged in Q1 2026.
  • Vanguard Extended Market ETF made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #179 holding.
  • Aspiriant LLC first reported a position in Vanguard Extended Market ETF in Q4 2021 and has held it in 18 quarters since.
  • Aspiriant LLC's Vanguard Extended Market ETF position peaked at $1.21M in Q3 2025.
  • 1,002 funds tracked by Wall St. Rank held Vanguard Extended Market ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.